Watchful monitoring for hepatitis B reactivation after intensive chemotherapy [1]

Annals of Oncology

Volumn 10, Issue 4, 1999, Pages 483-484

  Chalandon, Y ^a   Negro, F ^a   Hebert, D ^a   Dietrich, P Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; STEROID; VIRUS DNA;

ADULT; CASE REPORT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LETTER; LIVER TOXICITY; MALE; NONHODGKIN LYMPHOMA; ORCHIECTOMY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0032931826     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008377822464     Document Type: Letter

References (10)

1. Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336: 1290-7.
2. Hoofnagle JH, Dusheiko GM, Schafer DF et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 447-9.
3. Lok AS, Liang RH, Chiu EK et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100 (1): 182-8.
4. Nakamura Y, Motokura T, Fujita A et al. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991. Cancer 1996; 78 (10): 2210-5.
5. Tur-Kaspa R, Burk RD, Shaul Y et al. Hepatitis B virus DNA contains glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83 (6): 1627-31.
6. Kumagai K, Takagi T, Nakamura S et al. Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan. Ann Oncol 1997; 8 (Suppl 1): 107-9.
7. Omata M, Ehata T, Yokosuda O et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-704.
8. Rehermann B, Ferrari C, Pasquinelli C et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med 1996; 2 (10): 1104-8.
9. Penna A, Artini M, Cavalli A et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996; 98 (5): 1185-94.
10. Clark FL, Drummond MW, Chambers S et al. Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. Ann Oncol 1998; 9: 385-7.